Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226049994> ?p ?o ?g. }
- W4226049994 endingPage "e1010465" @default.
- W4226049994 startingPage "e1010465" @default.
- W4226049994 abstract "Although efficacious vaccines have significantly reduced the morbidity and mortality of COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet need is exacerbated by the emergence and spread of SARS-CoV-2 variants of concern (VOCs) that have shown some resistance to vaccine responses. Here we report the isolation of five neutralizing mAbs from an Indian convalescent donor, out of which two (THSC20.HVTR04 and THSC20.HVTR26) showed potent neutralization of SARS-CoV-2 VOCs at picomolar concentrations, including the Delta variant (B.1.617.2). One of these (THSC20.HVTR26) also retained activity against the Omicron variant. These two mAbs target non-overlapping epitopes on the receptor-binding domain (RBD) of the spike protein and prevent virus attachment to its host receptor, human angiotensin converting enzyme-2 (hACE2). Furthermore, the mAb cocktail demonstrated protection against the Delta variant at low antibody doses when passively administered in the K18 hACE2 transgenic mice model, highlighting their potential as a cocktail for prophylactic and therapeutic applications. Developing the capacity to rapidly discover and develop mAbs effective against highly transmissible pathogens like coronaviruses at a local level, especially in a low- and middle-income country (LMIC) such as India, will enable prompt responses to future pandemics as an important component of global pandemic preparedness." @default.
- W4226049994 created "2022-05-05" @default.
- W4226049994 creator A5003495794 @default.
- W4226049994 creator A5006124702 @default.
- W4226049994 creator A5007360478 @default.
- W4226049994 creator A5007715088 @default.
- W4226049994 creator A5009171598 @default.
- W4226049994 creator A5010797533 @default.
- W4226049994 creator A5013952922 @default.
- W4226049994 creator A5021465527 @default.
- W4226049994 creator A5026861087 @default.
- W4226049994 creator A5027390964 @default.
- W4226049994 creator A5031605065 @default.
- W4226049994 creator A5031766015 @default.
- W4226049994 creator A5034841206 @default.
- W4226049994 creator A5036808227 @default.
- W4226049994 creator A5047054446 @default.
- W4226049994 creator A5047662089 @default.
- W4226049994 creator A5047756432 @default.
- W4226049994 creator A5047879181 @default.
- W4226049994 creator A5048030644 @default.
- W4226049994 creator A5053277544 @default.
- W4226049994 creator A5053586864 @default.
- W4226049994 creator A5058904397 @default.
- W4226049994 creator A5060696547 @default.
- W4226049994 creator A5061744187 @default.
- W4226049994 creator A5062866836 @default.
- W4226049994 creator A5063915197 @default.
- W4226049994 creator A5064335115 @default.
- W4226049994 creator A5065372771 @default.
- W4226049994 creator A5075095640 @default.
- W4226049994 creator A5079409038 @default.
- W4226049994 creator A5080210042 @default.
- W4226049994 creator A5084157975 @default.
- W4226049994 creator A5084864678 @default.
- W4226049994 creator A5086096538 @default.
- W4226049994 date "2022-04-28" @default.
- W4226049994 modified "2023-09-30" @default.
- W4226049994 title "A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant" @default.
- W4226049994 cites W2028470175 @default.
- W4226049994 cites W2076449818 @default.
- W4226049994 cites W2104234755 @default.
- W4226049994 cites W2132629607 @default.
- W4226049994 cites W2161661741 @default.
- W4226049994 cites W2239363967 @default.
- W4226049994 cites W2578029714 @default.
- W4226049994 cites W3012831148 @default.
- W4226049994 cites W3025744748 @default.
- W4226049994 cites W3025871232 @default.
- W4226049994 cites W3034202401 @default.
- W4226049994 cites W3034548712 @default.
- W4226049994 cites W3035459690 @default.
- W4226049994 cites W3036529319 @default.
- W4226049994 cites W3042323010 @default.
- W4226049994 cites W3044660350 @default.
- W4226049994 cites W3080378920 @default.
- W4226049994 cites W3094688801 @default.
- W4226049994 cites W3125661530 @default.
- W4226049994 cites W3127852352 @default.
- W4226049994 cites W3131871667 @default.
- W4226049994 cites W3136437538 @default.
- W4226049994 cites W3136616180 @default.
- W4226049994 cites W3139036184 @default.
- W4226049994 cites W3144506870 @default.
- W4226049994 cites W3149102402 @default.
- W4226049994 cites W3155000349 @default.
- W4226049994 cites W3158955064 @default.
- W4226049994 cites W3159815948 @default.
- W4226049994 cites W3163666344 @default.
- W4226049994 cites W3165479483 @default.
- W4226049994 cites W3184172540 @default.
- W4226049994 cites W3184226105 @default.
- W4226049994 cites W3195038895 @default.
- W4226049994 cites W3196297007 @default.
- W4226049994 cites W3198233589 @default.
- W4226049994 cites W3198285117 @default.
- W4226049994 cites W3199849883 @default.
- W4226049994 cites W3200766981 @default.
- W4226049994 cites W3201073982 @default.
- W4226049994 cites W3205090915 @default.
- W4226049994 cites W3205588626 @default.
- W4226049994 cites W4200549894 @default.
- W4226049994 cites W4220673385 @default.
- W4226049994 cites W4221072241 @default.
- W4226049994 cites W4224950216 @default.
- W4226049994 cites W4225727012 @default.
- W4226049994 cites W4225932328 @default.
- W4226049994 cites W4226229183 @default.
- W4226049994 doi "https://doi.org/10.1371/journal.ppat.1010465" @default.
- W4226049994 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35482816" @default.
- W4226049994 hasPublicationYear "2022" @default.
- W4226049994 type Work @default.
- W4226049994 citedByCount "6" @default.
- W4226049994 countsByYear W42260499942022 @default.
- W4226049994 countsByYear W42260499942023 @default.
- W4226049994 crossrefType "journal-article" @default.
- W4226049994 hasAuthorship W4226049994A5003495794 @default.
- W4226049994 hasAuthorship W4226049994A5006124702 @default.